Dabur India targets double-digit FY27 growth as rural demand and hair oils recover

Investment View and Valuation

Prabhudas Lilladher’s July 29, 2026 Q1 FY27 result update on Dabur India retains a HOLD rating. The broker sees an encouraging demand outlook, supported by sequential recovery across most categories, healthy prospects for hair oils and foods, rural-market resilience, innovation and steady consolidated margin guidance.

However, Prabhudas Lilladher believes valuation limits major downside rather than offering scope for a substantial re-rating. Dabur India trades at 32.6x FY28E EPS, and sustained double-digit growth alongside successful execution of direct-to-consumer acquisitions is considered necessary for a long-term re-rating. The target price was raised marginally to Rs492 from Rs491, while the HOLD rating was retained.

Q1 FY27 Financial Performance

Dabur India reported consolidated revenue of Rs37,644 million in Q1 FY27, up 10.6 per cent year on year and broadly in line with Prabhudas Lilladher’s estimate of Rs37,621 million. EBITDA increased 11.0 per cent to Rs7,414 million, compared with the estimate of Rs7,392 million, while the EBITDA margin expanded 8 bps year on year to 19.7 per cent. Gross margin expanded 32 bps to 47.3 per cent. Adjusted PAT grew 15.3 per cent year on year to Rs5,862 million, 3.7 per cent above the broker’s estimate of Rs5,651 million.

Segment Performance

Segment performance was mixed but generally improved during the quarter. Hair oils grew 18 per cent, comprising 8 per cent volume growth and the balance from pricing. Oral care delivered high-single-digit growth, with Dabur Red, Dabur Herbal and the premium brand Meswak showing sustained traction. Herbal brands outpaced non-herbal brands by 550 bps in Q1 FY27. Skin care also grew at a high-single-digit rate.

Food and beverage grew 8 per cent. Glucose and health juices had a weak start because of unseasonal rain but recovered to mid-teen growth in May and June.

Demand and Growth Outlook

International business grew 15.5 per cent, led by Namaste, Turkey, the UK, Bangladesh, Nigeria, Egypt and the Sub-Saharan Africa region. MENA declined 5.4 per cent in rupee terms. Rural markets outperformed urban markets by 550 bps during Q1 FY27.

Management expects quarter-on-quarter acceleration in sales growth, supported by stable consumption and market initiatives. It expects double-digit hair-oil growth in FY27 and price-led double-digit consolidated sales growth, while acknowledging that elevated inflation could affect volumes. Management said rural demand has remained resilient despite an approximately 14-15 per cent rainfall deficit.

Strategic Initiatives and Capital Allocation

• Management plans approximately Rs4,000-5,000 million of capex in Tamil Nadu.
• The company is evaluating synergistic, reasonably valued mid-sized to large acquisitions.
• Dabur launched health supplements and nutraceuticals under the Signs brand as a direct-to-consumer healthcare play.
• Prabhudas Lilladher notes that acquisition execution must be monitored.

Earnings Estimates

Prabhudas Lilladher forecasts sales of Rs145,642 million in FY27E and Rs160,054 million in FY28E, with EBITDA margins of 18.7 per cent and 18.8 per cent, respectively. The broker estimates sales CAGR of 10.1 per cent and EPS CAGR of 11.3 per cent over FY27-FY28.

Key Risks

• A potential Super El Nino.
• Geopolitical disruption affecting India and the Middle East.
• Inflation-led pressure on volumes.
• Weaker rural demand if deficient rainfall persists.